Omega-3 Polyunsaturated Fatty Acids (PUFAs) – A Global Market Overview
REPORT SYNOPSIS
COVID-19 pandemic effect on the global Omega-3 ingredients market varied materially by country and end-use applications, depending on the timing of the outbreak and consumer behavior. Overall, the impact of coronavirus on global Omega-3 was moderate in 2020 and expected to recover significantly in 2021.
Omega-3s demand in animal/pet nutrition applications was least impacted by the pandemic, as these ingredients have been considered most essential for animal health. Demand from Omega-3s in pharmaceuticals was firm as these drugs are prescribed to at-risk patients. Strong increase in prescription levels was observed during the second half of 2020, partially offset by lower levels in the second quarter of the year.
Research Findings & Coverage
The report analyzes the global market for the following key material sources of Omega-3:
COVID-19 pandemic effect on the global Omega-3 ingredients market varied materially by country and end-use applications, depending on the timing of the outbreak and consumer behavior. Overall, the impact of coronavirus on global Omega-3 was moderate in 2020 and expected to recover significantly in 2021.
Omega-3s demand in animal/pet nutrition applications was least impacted by the pandemic, as these ingredients have been considered most essential for animal health. Demand from Omega-3s in pharmaceuticals was firm as these drugs are prescribed to at-risk patients. Strong increase in prescription levels was observed during the second half of 2020, partially offset by lower levels in the second quarter of the year.
Research Findings & Coverage
- Worldwide market for Oemga-3 is analyzed in this report with respect to raw material sources and end-use applications
- Omega-3 market size is reported in this study by raw material source and end-use application across all major regions/countries
- Dismissal of Amarin Pharma’s Lawsuit Exonerates the Omega-3 Dietary Supplement Industry
- Docosapentaenoic Acid (DPA) Reappears on the Omega-3 Fatty Acid Horizon
- Algae Sources Offer Immense Scope for Global Omega-3s Market
- Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
- Major companies profiled – 124
- The industry guide includes the contact details for 319 companies
The report analyzes the global market for the following key material sources of Omega-3:
- Marine
- Algal
- Dietary Supplements
- Animal Nutrition
- Food & Beverages
- Infant Nutrition
- Pharmaceuticals
- Clinical Nutrition
- The report reviews, analyzes and projects the global Omega-3 market for the period 2017-2026 in terms of market value in US$ and volume in metric tons; and the compound annual growth rates (CAGRs) projected from 2019 through 2026 with a special focus on y-o-y for 2019-2020
- North America (The United States, Canada and Mexico)
- Europe (Denmark, France, Germany, Italy, Norway, Spain, the United Kingdom and Rest of Europe)
- Asia-Pacific (Australia, China, Japan, India, South Korea and Rest of Asia-Pacific)
- South America (Argentina, Brazil and Rest of South America)
- Rest of World
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
COVID-19 Impact on the Global Omega-3 PUFAs Market
1.1 Product Outline
1.1.1 What is Omega-3?
1.1.1.1 Fatty Acids
1.1.1.1.1 Saturated Fatty Acids
1.1.1.1.2 Unsaturated Fatty Acids
1.1.1.1.3 Polyunsaturated Fatty Acids (PUFAs)
1.1.1.2 Omega-3 Fatty Acids
1.1.1.2.1 Categories of Omega-3 Fatty Acids
1.1.1.2.1.1 Short Chain Omega-3 Fatty Acids
1.1.1.2.1.1.1 Alpha-Linolenic Acid (ALA)
1.1.1.2.1.2 Long Chain Omega-3 Fatty Acids (LC-PUFAs)
1.1.1.2.1.2.1 Docosahexaenoic Acid (DHA)
1.1.1.2.1.2.2 Eicosapentaenoic Acid (EPA)
1.1.2 Dietary Sources of Omega-3 Fatty Acids
1.1.3 Omega-3 and Its Health Benefits
1.1.3.1 High Cholesterol
1.1.3.2 High Blood Pressure
1.1.3.3 Heart Disease
1.1.3.4 Diabetes
1.1.3.5 Rheumatoid Arthritis (RA)
1.1.3.6 Systemic Lupus Erythematosus (SLE)
1.1.3.7 Osteoporosis
1.1.3.8 Depression
1.1.3.9 Bipolar Disorder
1.1.3.10 Schizophrenia
1.1.3.11 Attention Deficit/Hyperactivity Disorder (ADHD)
1.1.3.12 Cognitive Decline
1.1.3.13 Skin Disorders
1.1.3.14 Inflammatory Bowel Disease (IBD)
1.1.3.15 Asthma
1.1.3.16 Macular Degeneration
1.1.3.17 Menstrual Pain
1.1.3.18 Colon Cancer
1.1.3.19 Breast Cancer
1.1.3.20 Prostate Cancer
1.2 Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
1.2.1 Marine Oils
1.2.1.1 Fish Oil
1.2.1.2 Krill Oil
1.2.1.3 Other Marine Sources
1.2.2 Algae
1.2.3 Plants
1.2.4 To Conclude
1.3 Evolution of Omega-3 Fatty Acid Ingredient Forms
1.3.1 First Generation Omega-3 Forms
1.3.2 Second Generation Omega-3 Forms
1.3.3 Third Generation Omega-3 Forms
1.4 Omega-3 PUFA Ingredient Type Analysis
1.4.1 18/12 (30% Omega-3) Fish Oils
1.4.2 Cod Liver Oils
1.4.3 Tuna Oils
1.4.4 Salmon Oils
1.4.5 Omega-3 Low Concentrate (40% to 55%) PUFAs
1.4.6 Omega-3 Medium Concentrate (60% to 80%) PUFAs
1.4.7 Omega-3 High Concentrate (above 85%) PUFAs
1.4.8 Krill Omega-3
1.4.9 Algal Omega-3
1.4.10 Other Omega-3 PUFAs
1.5 Omega-3 PUFA End-Use Application Analysis
1.5.1 Dietary Supplements
1.5.2 Animal Nutrition
1.5.3 Food & Beverages
1.5.4 Infant Nutrition
1.5.5 Pharmaceuticals
1.5.6 Clinical Nutrition
1.6 Manufacturing Processes for Omega-3 Fatty Acids
1.6.1 Chemistry of Omega-3 Fatty Acids
1.6.2 Processing of Fish Oils
1.6.3 Decontamination
1.6.4 Concentration Process
1.6.5 Production Technologies used for Omega-3 Fatty Acid Concentrates
1.6.5.1 Chromatographic Methods
1.6.5.2 Distillation Method
1.6.5.3 Molecular Distillation (MD)
1.6.5.4 Low-Temperature Crystallization
1.6.5.5 Urea Complexation/Precipitation
1.6.5.6 Enzymatic Methods
1.6.5.6.1 Lipase-Catalyzed Hydrolysis
1.6.5.6.2 Lipase-Catalyzed Esterification
1.6.5.7 Supercritical Fluid Technology (SFT)
1.6.5.7.1 Supercritical Fluid Extraction (SFE)
1.6.5.7.2 Supercritical Fluid Chromatography (SFC)
1.6.6 Microalgae Production
1.6.7 Microalgae as Sources of n-3 LC-PUFA
1.6.8 Algae Oil Extraction
1.6.9 In Conclusion
2. REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS WORLDWIDE
2.1 Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
2.2 Health Claim Approvals
2.2.1 FDA Approved Health Claims
2.2.2 EFSA Approved Health Claims
2.2.3 Approved Health Claims in Other Regions
2.2.3.1 Canada
2.2.3.2 Australia and New Zealand
2.2.3.3 Japan
2.3 Pharmaceutical Omega-3 Drugs Approvals
2.4 Regulations and Standards for Fish oils
3. KEY MARKET TRENDS
3.1 Dismissal of Amarin Pharma’s Lawsuit Exonerates the Omega-3 Dietary Supplement Industry
3.2 Docosapentaenoic Acid (DPA) Reappears on the Omega-3 Fatty Acid Horizon
3.3 Robust Growth for Highly Concentrated Omega-3 Ingredients Bolstered by Demand from Pharma and Dietary Supplements Markets
3.4 Algae Sources Offer Immense Scope for Global Omega-3s Market
4. KEY GLOBAL PLAYERS
Aker Biomarine AS (Norway)
Archer Daniels Midland Company (United States)
Austral Group S.A.A. (Peru)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Cellana LLC (United States)
Chemport, Inc. (South Korea)
Croda International PLC (United Kingdom)
Denomega (Orkla Health) (Norway)
DSM Nutritional Products AG (Switzerland)
Epax AS (Norway)
Evonik Nutrition & Care GmbH (Germany)
GC Rieber VivoMega AS (Norway)
Golden Omega SA (Chile)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
KD Pharma Group SA(Switzerland)
LYSI Hf. (Iceland)
Nippon Suisan Kaisha, Ltd. (Nissui) (Japan)
Novasep Holding SAS (France)
Olvea Fish Oils (Olvea Group) (France)
Omega Protein Corporation (United States)
Polaris (France)
Qualitas Health Inc (United States)
Seven Seas Ltd (United Kingdom)
Sinomega Biotech Engineering Co Ltd (China)
Solutex GC, S.L. (Spain)
Stepan Company (United States)
TASA Omega SA (Tecnol?gica De Alimentos SA) (Peru)
Thai Union Group PCL (Thailand)
Wiley Companies (United States)
5. KEY BUSINESS AND PRODUCT TRENDS
Aker BioMarine in a Research Collaboration for Alzheimer’s with LPC-bound EPA/DHA
Aker BioMarine in an Agreement to Develop Therapies for Brain and Eye Health Based on its LYSOVETA Product
Meelung Trading Co. Ltd to Distribute GC Rieber’s VivoMega Omega-3 oils in Taiwan
Bioscope Viet Nam to Distribute GC Rieber’s VivoMega in Vietnam
Epax Norway to Research for New Marine Fatty Acids
Aker BioMarine Launches LYSOVETA Business Segment
GC Rieber Oils Renamed as GC Rieber VivoMega
Thai Union to expand Adoption of Corbion’s Algaprime DHA into Shrimp Aquaculture
KD Pharma Group Launches MOVE3 Softgels in co-operation with Stratum Nutrition
DSM Introduces life’sDHA SF55-O200DS High Potency DHA Oils
New Drug Candidate from KD Pharma Group and SLA Pharma Enters into Covid-19 Clinical Trial
Matinas BioPharma Initiates ENHANCE-IT Study of MAT9001 Against Vascepa
Wiley Companies Launches MSC-certified Omega-3 Concentrate Powder
Kirk Kapital Acquires Stake in GC Rieber VivoMega
GC Rieber Oils Collaborates with Barrington Nutritionals to Distribute VivoMega Omega-3 Fish Oils
Vascepa is Now the First and Only FDA-Approved Drug for Reducing Cardiovascular Risk
US FDA Acknowledged Aker BioMarine QRILL Pet as GRAS
Two-Year Krill Oil Supply Pact Formed by Acasti and Aker BioMarine
Epax to Increase Production Capacity of Omega-3 Oils by Over 50% by 2021
Continued Expansion of BioMar Feed with AlgaPrime DHA
Progress in Acasti's TRILOGY Phase 3 Clinical Trials in Severe Hypertriglyceridemia Patients
Omegavie DHA 700 Algae Sensory Oil Launched by Polaris
NRC IRAP Awarded Funding to Acasti Pharma to Enhance CaPre Production Capacity
USDA Deregulated Cargill's Proprietary Canola for Cultivation in the United States
US PTO Granted Patent for Aker BioMarine's Flexitech Technology
Commercial Production of Omega-3 Fatty Acids Started in Veramaris Facility
Arctic Nutrition Joined Forces with Kotler to Gain Entry into the Chinese Market
ADM Along with Qualitas Health Introduces a New Line of Algal DHA and EPA Blends
Nesher Pharmaceuticals' Omega-3-Acid Ethyl Esters Capsules Receives Market Approval from FDA
KD Pharma to Expand its Leading Position in the Omega-3 Pharmaceutical Market
HLS Therapeutics Filed a New Drug Submission with Health Canada for Vascepa
KD Nutra Completes Clinical Trial for its Move3 Omega-3 Joint Formula
OmegaTri Acquired by Golden Omega
Lyxia | Xiaozao Tech Completes the Construction of Level A Downstream Algae Extraction Line
Lyxia | Xiaozao Tech to Establish Microalgae Cultivation Facility in Portugal
OLVEA and IQI Inks Deal to Enhance Their Business Quality
Commercial Production of Salmon Fed on Omega-3 Marine Algal Oil by Lingalaks
Marine Ingredients and InnovaGel Combined Systems to Become KD Nutra
Merck KGaA's Consumer Health Business Acquired by P&G
Commissioning of Thai Union Marine Nutrients Tuna Oil Refinery in Rostock, Germany
Mowi is the New Name for Marine Harvest
Supplementation with One Gram of Omacor Lowers Occurrence of Myocardial Infarction in Low Risk Patients
Launch of Onavita Algal DHA Powder by ADM
Lyxia Starts Broadening Algae Cultivation Operations Facility in China
Introduction of a Sustainable Plant-Based Fish Oil Alternative Launched by Cargill
Large-Scale Shrimp Feeding Trial Using Feed Formulated with Cellana's Algae Biomass Conducted by Thai Company
USDA Deregulated Nuseed's Proprietary Omega-3 Canola for Cultivation in US
ArcticSource1 and Fam-Trade Form Omega-3 Oil Distribution Pact
6. GLOBAL MARKET OVERVIEW
6.1 Global Omega-3 PUFAs Market Overview by End-use Application
6.1.1 Global Omega-3 PUFAs End-use Application Market Overview by Geographic Region
6.1.1.1 Dietary Supplements
6.1.1.2 Animal Nutrition
6.1.1.3 Food & Beverages
6.1.1.4 Infant Nutrition
6.1.1.5 Pharmaceuticals
6.1.1.6 Clinical Nutrition
6.2 Global Omega-3 PUFAs Market Overview by Raw Material Source
6.2.1 Global Omega-3 PUFAs Raw Material Source Market Overview by Geographic Region
6.2.1.1 Marine Omega-3 PUFAs
6.2.1.2 Algal Omega-3 PUFAs
6.3 Global Omega-3 PUFAs Market Overview by Ingredient Type
PART B: REGIONAL MARKET PERSPECTIVE
Global Omega-3 PUFAs Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
7.1 North America Omega-3 PUFAs Market Overview by Geographic Region
7.2 North American Omega-3 PUFAs Market Overview by Raw Material Source
7.3 North America Omega-3 PUFAs Market Overview by End-Use Application
7.4 Major Market Players
Aker BioMarine Manufacturing LLC (United States)
Alaska Protein Recovery, LLC (United States)
Algae to Omega (United States)
Algarithm Ingredients, Inc. (Canada)
Algisys, LLC (United States)
Archer Daniels Midland Company (United States)
Cellana LLC (United States)
Corbion, Inc. (United States)
Felda IFFCO LLC (United States)
SourceOne Global Partners
GCI Nutrients, Inc. (United States)
Helios Corp (United States)
Mara Renewables Corporation (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Oceans Omega, LLC (United States)
Omega Protein Corporation (United States)
Qualitas Health Inc (United States)
Rimfrost USA, LLC (United States)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
Stepan Company (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley Companies (United States)
8. EUROPE
8.1 European Omega-3 PUFAs Market Overview by Geographic Region
8.2 European Omega-3 PUFAs Market Overview by Raw Material Source
8.3 European Omega-3 PUFAs Market Overview by End-Use Application
8.4 Major Market Players
Aker Biomarine AS (Norway)
AlgaeCytes Limited (United Kingdom)
Anklam Extrakt GmbH (Germany)
Arctic Nutrition AS (Norway)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Biosearch, S.A. (Biosearch Life) (Spain)
Bluebiotech International GmbH (Germany)
Brudy Technology S.L. (Spain)
COPALIS (France)
Croda International Plc (United Kingdom)
De Wit Speciality Oils (Netherlands)
Denomega (Orkla Health) (Norway)
DSM Nutritional Products AG (Switzerland)
Epax AS (Norway)
Evonik Nutrition & Care GmbH (Germany)
Fermentalg SA (France)
Antibi?ticos de Le?n SLU (ADL Biopharma) (Spain)
Fortuna Oils AS (Norway)
GC Rieber Oils (Norway)
Henry Lamotte Oils GmbH (Germany)
Hofseth Biocare AS (Norway)
Imperial-Oel-Import Handelsgesellschaft mbH (Germany)
IQI B.V. (Netherlands)
KD Pharma Group (Switzerland)
LYSI hf. (Iceland)
Margildi EHF. (Iceland)
Minami Nutrition (Belgium)
Mowi ASA (Norway)
Noble Harvest AS (Norway)
Norwegian Fish Oil AS (Norway)
Novasep Holding SAS (France)
Olvea Fish Oils (Olvea Group) (France)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
POLARIS (France)
Progress Biotech bv (The Netherlands)
Rimfrost AS (Norway)
Seafoodia (France)
SEANOVA (France)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
Sochim International SPA (Italy)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (Netherlands)
Thai Union Marine Nutrients GmbH (Germany)
Triplenine Group A/S (Denmark)
True Westfjords ehf (Iceland)
Vesteraalens AS (Norway)
Veramaris V.O.F. (Netherlands)
9. ASIA-PACIFIC
9.1 Asia-Pacific Omega-3 PUFAs Market Overview by Geographic Region
9.2 Asia-Pacific Omega-3 PUFAs Market Overview by Raw Material Source
9.3 Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
9.4 Major Market Players
AK & MN Biofarm Co Ltd (South Korea)
Arjuna Natural Pvt Ltd (India)
Avesthagen Limited (India)
Bioplus Life Sciences Pvt. Ltd. (India)
Bizen Chemical Co Ltd (Japan)
Blueline Foods (India) Pvt Ltd (India)
Chemport, Inc. (South Korea)
Clover Corporation (Nu-Mega) (Australia)
Coastal Exports Corporation (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India Glycols Ltd) (India)
Fenchem Biotek Ltd (China)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Jiangsu Weisikang Food Sci-Tech Development Co., Ltd. (China)
K Pharmtech Co. Ltd. (South Korea)
Kangcare Bioindustry Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Luhua Biomarine (Shandong) Co., Ltd (China)
Maruha Nichiro Corporation (Japan)
Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Phycoil Biotech Korea, Inc. (South Korea)
Qingdao Kangjing Marine Biotechnology Co., Ltd (China)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Yuwang Pharmaceutical Co., Ltd (China)
Shenzhen Qianhai Xiaozao Technology Ltd./ Lyxia Corporation (China)
Sinomega Biotech Engineering Co Ltd (China)
Skuny Bioscience Co., Ltd. (China)
Thai Union Group PCL (Thailand)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
10. SOUTH AMERICA
10.1 South American Omega-3 PUFAs Market Overview by Geographic Region
10.2 South American Omega-3 PUFAs Market Overview by Raw Material Source
10.3 South American Omega-3 PUFAs Market Overview by End-Use Application
10.4 Major Market Players
AntarcticOmega SPA (Chile)
Austral Group S.A.A. (Peru)
Colpex International S.A.C (Peru)
Corporacion Pesquera Inca S.A.C. (Peru)
Cox & Compa??a S.A. (Chile)
Fiordo Austral Group (Chile)
GIHON – Laboratorios Qu?micos Srl (Argentina)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
SPES S.A. (Chile)
TASA Omega SA (Tecnol?gica De Alimentos SA) (Peru)
11. REST OF WORLD
11.1 Rest of World Omega-3 PUFAs Market Overview by Raw Material Source
11.2 Rest of World Omega-3 PUFAs Market Overview by End-Use Application
PART C: OMEGA-3 PATENT LANDSCAPE
PART D: GUIDE TO THE INDUSTRY
1. MANUFACTURERS OF OMEGA-3 INGREDIENTS
2. RAW MATERIAL PRODUCERS AND EQUIPMENT SUPPLIERS
3. MAJOR INGREDIENT DISTRIBUTORS
4. OMEGA-3 END-USERS
PART E: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
CHARTS & GRAPHS
PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Omega-3 PUFAs Market Analysis by Geographic Region (2019, 2020 & 2026)
Chart 2: Global Omega-3 PUFAs Market Analysis by Raw Material Source (2019, 2020 & 2026)
Chart 3: Global Omega-3 PUFAs Market Analysis by End-use Application (2019, 2020 & 2026)
Chart 4: 2020 Snapshot for Global Omega-3 PUFAs Market Share by Ingredient Type
Chart 5: Global 18/12 Fish Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 6: Global Cod Liver Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 7: Global Tuna Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 8: Global Salmon Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 9: Global Low Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 10: Global Medium Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 11: Global High Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 12: Global Krill Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 13: Global Algal Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 14: Global Other Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 15: 2020 Snapshot for Global Omega3 PUFAs Market Share by End-Use Application
Chart 16: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Dietary Supplements – Volume in Metric Tons and Value in USD Million
Chart 17: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Animal Nutrition – Volume in Metric Tons and Value in USD Million
Chart 18: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Food & Beverages – Volume in Metric Tons and Value in USD Million
Chart 19: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Infant Nutrition – Volume in Metric Tons and Value in USD Million
Chart 20: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Pharmaceuticals – Volume in Metric Tons and Value in USD Million
Chart 21: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Clinical Nutrition – Volume in Metric Tons and Value in USD Million
Chart 22: Global Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 23: Global Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 24: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 25: Global Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 26: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 27: Global Omega-3 PUFAs Market Analysis (2017-2026) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 28: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 29: Global Omega-3 PUFAs Market Analysis (2017-2026) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 30: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 31: Global Omega-3 PUFAs Market Analysis (2017-2026) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 32: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 33: Global Omega-3 PUFAs Market Analysis (2017-2026) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 34: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 35: Global Omega-3 PUFAs Market Analysis (2017-2026) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 36: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 37: Global Omega-3 PUFAs Market Analysis (2017-2026) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 38: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 39: Global Omega-3 PUFAs Market Analysis (2017-2026) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 40: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 41: Global Omega-3 PUFAs Market Analysis (2017-2026) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 42: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 43: Global Omega-3 PUFAs Market Analysis (2017-2026) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific in Metric Tons
Chart 44: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific
Chart 45: Global Omega-3 PUFAs Market Analysis (2017-2026) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific in USD Million
Chart 46: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific
Chart 47: Global Omega-3 PUFAs Market Analysis (2017-2026) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 48: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 49: Global Omega-3 PUFAs Market Analysis (2017-2026) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 50: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 51: Global Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 52: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 53: Global Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 54: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 55: Global Marine Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 56: Glance at 2017, 2020 and 2026 Global Marine Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 57: Global Marine Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 58: Glance at 2017, 2020 and 2026 Global Marine Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 59: Global Algal Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 60: Glance at 2017, 2020 and 2026 Global Algal Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 61: Global Algal Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 62: Glance at 2017, 2020 and 2026 Global Algal Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 63: Global Omega-3 PUFAs Market Analysis (2017-2026) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in Metric Tons
Chart 64: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others
Chart 65: Global Omega-3 PUFAs Market Analysis (2017-2026) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in USD Million
Chart 66: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others
PART B: REGIONAL MARKET PERSPECTIVE
Chart 67: Global Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 68: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 69: Global Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 70: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
REGIONAL MARKET OVERVIEW
NORTH AMERICA
Chart 71: North American Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 72: North American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – United States, Canada and Mexico in Metric Tons
Chart 73: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 74: North American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 75: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 76: North American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 77: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 78: North American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 79: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 80: North American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 81: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 82: North American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 83: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
EUROPE
Chart 84: European Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 85: European Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in Metric Tons
Chart 86: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
Chart 87: European Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in USD Million
Chart 88: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
Chart 89: European Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 90: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 91: European Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 92: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 93: European Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 94: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 95: European Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 96: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
ASIA-PACIFIC
Chart 97: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 98: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in Metric Tons
Chart 99: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
Chart 100: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in USD Million
Chart 101: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
Chart 102: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 103: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 104: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 105: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 106: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 107: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 108: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 109: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
SOUTH AMERICA
Chart 110: South American Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 111: South American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Argentina, Brazil and Rest of South America in Metric Tons
Chart 112: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Argentina, Brazil and Rest of South America
Chart 113: South American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Argentina, Brazil and Rest of South America in USD Million
Chart 114: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by Geographic Region – Argentina, Brazil and Rest of South America
Chart 115: South American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 116: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 117: South American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 118: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 119: South American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
Chart 120: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
Chart 121: South American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
Chart 122: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
REST OF WORLD
Chart 123: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 124: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 125: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 126: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 127: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 128: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
Chart 129: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
Chart 130: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
Chart 131: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
1. INTRODUCTION
COVID-19 Impact on the Global Omega-3 PUFAs Market
1.1 Product Outline
1.1.1 What is Omega-3?
1.1.1.1 Fatty Acids
1.1.1.1.1 Saturated Fatty Acids
1.1.1.1.2 Unsaturated Fatty Acids
1.1.1.1.3 Polyunsaturated Fatty Acids (PUFAs)
1.1.1.2 Omega-3 Fatty Acids
1.1.1.2.1 Categories of Omega-3 Fatty Acids
1.1.1.2.1.1 Short Chain Omega-3 Fatty Acids
1.1.1.2.1.1.1 Alpha-Linolenic Acid (ALA)
1.1.1.2.1.2 Long Chain Omega-3 Fatty Acids (LC-PUFAs)
1.1.1.2.1.2.1 Docosahexaenoic Acid (DHA)
1.1.1.2.1.2.2 Eicosapentaenoic Acid (EPA)
1.1.2 Dietary Sources of Omega-3 Fatty Acids
1.1.3 Omega-3 and Its Health Benefits
1.1.3.1 High Cholesterol
1.1.3.2 High Blood Pressure
1.1.3.3 Heart Disease
1.1.3.4 Diabetes
1.1.3.5 Rheumatoid Arthritis (RA)
1.1.3.6 Systemic Lupus Erythematosus (SLE)
1.1.3.7 Osteoporosis
1.1.3.8 Depression
1.1.3.9 Bipolar Disorder
1.1.3.10 Schizophrenia
1.1.3.11 Attention Deficit/Hyperactivity Disorder (ADHD)
1.1.3.12 Cognitive Decline
1.1.3.13 Skin Disorders
1.1.3.14 Inflammatory Bowel Disease (IBD)
1.1.3.15 Asthma
1.1.3.16 Macular Degeneration
1.1.3.17 Menstrual Pain
1.1.3.18 Colon Cancer
1.1.3.19 Breast Cancer
1.1.3.20 Prostate Cancer
1.2 Evolution of Raw Material Sources for Omega-3 Polyunsaturated Fatty Acids (PUFAs)
1.2.1 Marine Oils
1.2.1.1 Fish Oil
1.2.1.2 Krill Oil
1.2.1.3 Other Marine Sources
1.2.2 Algae
1.2.3 Plants
1.2.4 To Conclude
1.3 Evolution of Omega-3 Fatty Acid Ingredient Forms
1.3.1 First Generation Omega-3 Forms
1.3.2 Second Generation Omega-3 Forms
1.3.3 Third Generation Omega-3 Forms
1.4 Omega-3 PUFA Ingredient Type Analysis
1.4.1 18/12 (30% Omega-3) Fish Oils
1.4.2 Cod Liver Oils
1.4.3 Tuna Oils
1.4.4 Salmon Oils
1.4.5 Omega-3 Low Concentrate (40% to 55%) PUFAs
1.4.6 Omega-3 Medium Concentrate (60% to 80%) PUFAs
1.4.7 Omega-3 High Concentrate (above 85%) PUFAs
1.4.8 Krill Omega-3
1.4.9 Algal Omega-3
1.4.10 Other Omega-3 PUFAs
1.5 Omega-3 PUFA End-Use Application Analysis
1.5.1 Dietary Supplements
1.5.2 Animal Nutrition
1.5.3 Food & Beverages
1.5.4 Infant Nutrition
1.5.5 Pharmaceuticals
1.5.6 Clinical Nutrition
1.6 Manufacturing Processes for Omega-3 Fatty Acids
1.6.1 Chemistry of Omega-3 Fatty Acids
1.6.2 Processing of Fish Oils
1.6.3 Decontamination
1.6.4 Concentration Process
1.6.5 Production Technologies used for Omega-3 Fatty Acid Concentrates
1.6.5.1 Chromatographic Methods
1.6.5.2 Distillation Method
1.6.5.3 Molecular Distillation (MD)
1.6.5.4 Low-Temperature Crystallization
1.6.5.5 Urea Complexation/Precipitation
1.6.5.6 Enzymatic Methods
1.6.5.6.1 Lipase-Catalyzed Hydrolysis
1.6.5.6.2 Lipase-Catalyzed Esterification
1.6.5.7 Supercritical Fluid Technology (SFT)
1.6.5.7.1 Supercritical Fluid Extraction (SFE)
1.6.5.7.2 Supercritical Fluid Chromatography (SFC)
1.6.6 Microalgae Production
1.6.7 Microalgae as Sources of n-3 LC-PUFA
1.6.8 Algae Oil Extraction
1.6.9 In Conclusion
2. REGULATORY LANDSCAPE FOR OMEGA-3 FATTY ACIDS WORLDWIDE
2.1 Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake
2.2 Health Claim Approvals
2.2.1 FDA Approved Health Claims
2.2.2 EFSA Approved Health Claims
2.2.3 Approved Health Claims in Other Regions
2.2.3.1 Canada
2.2.3.2 Australia and New Zealand
2.2.3.3 Japan
2.3 Pharmaceutical Omega-3 Drugs Approvals
2.4 Regulations and Standards for Fish oils
3. KEY MARKET TRENDS
3.1 Dismissal of Amarin Pharma’s Lawsuit Exonerates the Omega-3 Dietary Supplement Industry
3.2 Docosapentaenoic Acid (DPA) Reappears on the Omega-3 Fatty Acid Horizon
3.3 Robust Growth for Highly Concentrated Omega-3 Ingredients Bolstered by Demand from Pharma and Dietary Supplements Markets
3.4 Algae Sources Offer Immense Scope for Global Omega-3s Market
4. KEY GLOBAL PLAYERS
Aker Biomarine AS (Norway)
Archer Daniels Midland Company (United States)
Austral Group S.A.A. (Peru)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Cellana LLC (United States)
Chemport, Inc. (South Korea)
Croda International PLC (United Kingdom)
Denomega (Orkla Health) (Norway)
DSM Nutritional Products AG (Switzerland)
Epax AS (Norway)
Evonik Nutrition & Care GmbH (Germany)
GC Rieber VivoMega AS (Norway)
Golden Omega SA (Chile)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
KD Pharma Group SA(Switzerland)
LYSI Hf. (Iceland)
Nippon Suisan Kaisha, Ltd. (Nissui) (Japan)
Novasep Holding SAS (France)
Olvea Fish Oils (Olvea Group) (France)
Omega Protein Corporation (United States)
Polaris (France)
Qualitas Health Inc (United States)
Seven Seas Ltd (United Kingdom)
Sinomega Biotech Engineering Co Ltd (China)
Solutex GC, S.L. (Spain)
Stepan Company (United States)
TASA Omega SA (Tecnol?gica De Alimentos SA) (Peru)
Thai Union Group PCL (Thailand)
Wiley Companies (United States)
5. KEY BUSINESS AND PRODUCT TRENDS
Aker BioMarine in a Research Collaboration for Alzheimer’s with LPC-bound EPA/DHA
Aker BioMarine in an Agreement to Develop Therapies for Brain and Eye Health Based on its LYSOVETA Product
Meelung Trading Co. Ltd to Distribute GC Rieber’s VivoMega Omega-3 oils in Taiwan
Bioscope Viet Nam to Distribute GC Rieber’s VivoMega in Vietnam
Epax Norway to Research for New Marine Fatty Acids
Aker BioMarine Launches LYSOVETA Business Segment
GC Rieber Oils Renamed as GC Rieber VivoMega
Thai Union to expand Adoption of Corbion’s Algaprime DHA into Shrimp Aquaculture
KD Pharma Group Launches MOVE3 Softgels in co-operation with Stratum Nutrition
DSM Introduces life’sDHA SF55-O200DS High Potency DHA Oils
New Drug Candidate from KD Pharma Group and SLA Pharma Enters into Covid-19 Clinical Trial
Matinas BioPharma Initiates ENHANCE-IT Study of MAT9001 Against Vascepa
Wiley Companies Launches MSC-certified Omega-3 Concentrate Powder
Kirk Kapital Acquires Stake in GC Rieber VivoMega
GC Rieber Oils Collaborates with Barrington Nutritionals to Distribute VivoMega Omega-3 Fish Oils
Vascepa is Now the First and Only FDA-Approved Drug for Reducing Cardiovascular Risk
US FDA Acknowledged Aker BioMarine QRILL Pet as GRAS
Two-Year Krill Oil Supply Pact Formed by Acasti and Aker BioMarine
Epax to Increase Production Capacity of Omega-3 Oils by Over 50% by 2021
Continued Expansion of BioMar Feed with AlgaPrime DHA
Progress in Acasti's TRILOGY Phase 3 Clinical Trials in Severe Hypertriglyceridemia Patients
Omegavie DHA 700 Algae Sensory Oil Launched by Polaris
NRC IRAP Awarded Funding to Acasti Pharma to Enhance CaPre Production Capacity
USDA Deregulated Cargill's Proprietary Canola for Cultivation in the United States
US PTO Granted Patent for Aker BioMarine's Flexitech Technology
Commercial Production of Omega-3 Fatty Acids Started in Veramaris Facility
Arctic Nutrition Joined Forces with Kotler to Gain Entry into the Chinese Market
ADM Along with Qualitas Health Introduces a New Line of Algal DHA and EPA Blends
Nesher Pharmaceuticals' Omega-3-Acid Ethyl Esters Capsules Receives Market Approval from FDA
KD Pharma to Expand its Leading Position in the Omega-3 Pharmaceutical Market
HLS Therapeutics Filed a New Drug Submission with Health Canada for Vascepa
KD Nutra Completes Clinical Trial for its Move3 Omega-3 Joint Formula
OmegaTri Acquired by Golden Omega
Lyxia | Xiaozao Tech Completes the Construction of Level A Downstream Algae Extraction Line
Lyxia | Xiaozao Tech to Establish Microalgae Cultivation Facility in Portugal
OLVEA and IQI Inks Deal to Enhance Their Business Quality
Commercial Production of Salmon Fed on Omega-3 Marine Algal Oil by Lingalaks
Marine Ingredients and InnovaGel Combined Systems to Become KD Nutra
Merck KGaA's Consumer Health Business Acquired by P&G
Commissioning of Thai Union Marine Nutrients Tuna Oil Refinery in Rostock, Germany
Mowi is the New Name for Marine Harvest
Supplementation with One Gram of Omacor Lowers Occurrence of Myocardial Infarction in Low Risk Patients
Launch of Onavita Algal DHA Powder by ADM
Lyxia Starts Broadening Algae Cultivation Operations Facility in China
Introduction of a Sustainable Plant-Based Fish Oil Alternative Launched by Cargill
Large-Scale Shrimp Feeding Trial Using Feed Formulated with Cellana's Algae Biomass Conducted by Thai Company
USDA Deregulated Nuseed's Proprietary Omega-3 Canola for Cultivation in US
ArcticSource1 and Fam-Trade Form Omega-3 Oil Distribution Pact
6. GLOBAL MARKET OVERVIEW
6.1 Global Omega-3 PUFAs Market Overview by End-use Application
6.1.1 Global Omega-3 PUFAs End-use Application Market Overview by Geographic Region
6.1.1.1 Dietary Supplements
6.1.1.2 Animal Nutrition
6.1.1.3 Food & Beverages
6.1.1.4 Infant Nutrition
6.1.1.5 Pharmaceuticals
6.1.1.6 Clinical Nutrition
6.2 Global Omega-3 PUFAs Market Overview by Raw Material Source
6.2.1 Global Omega-3 PUFAs Raw Material Source Market Overview by Geographic Region
6.2.1.1 Marine Omega-3 PUFAs
6.2.1.2 Algal Omega-3 PUFAs
6.3 Global Omega-3 PUFAs Market Overview by Ingredient Type
PART B: REGIONAL MARKET PERSPECTIVE
Global Omega-3 PUFAs Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
7. NORTH AMERICA
7.1 North America Omega-3 PUFAs Market Overview by Geographic Region
7.2 North American Omega-3 PUFAs Market Overview by Raw Material Source
7.3 North America Omega-3 PUFAs Market Overview by End-Use Application
7.4 Major Market Players
Aker BioMarine Manufacturing LLC (United States)
Alaska Protein Recovery, LLC (United States)
Algae to Omega (United States)
Algarithm Ingredients, Inc. (Canada)
Algisys, LLC (United States)
Archer Daniels Midland Company (United States)
Cellana LLC (United States)
Corbion, Inc. (United States)
Felda IFFCO LLC (United States)
SourceOne Global Partners
GCI Nutrients, Inc. (United States)
Helios Corp (United States)
Mara Renewables Corporation (Canada)
Nordic Naturals, Inc. (United States)
Novotech Nutraceuticals, Inc. (United States)
Oceans Omega, LLC (United States)
Omega Protein Corporation (United States)
Qualitas Health Inc (United States)
Rimfrost USA, LLC (United States)
Solarvest Bioenergy Inc. (Canada)
Source-Omega LLC (United States)
Stepan Company (United States)
The Wright Group (United States)
Virun, Inc. (United States)
Wiley Companies (United States)
8. EUROPE
8.1 European Omega-3 PUFAs Market Overview by Geographic Region
8.2 European Omega-3 PUFAs Market Overview by Raw Material Source
8.3 European Omega-3 PUFAs Market Overview by End-Use Application
8.4 Major Market Players
Aker Biomarine AS (Norway)
AlgaeCytes Limited (United Kingdom)
Anklam Extrakt GmbH (Germany)
Arctic Nutrition AS (Norway)
BASF SE (Germany)
Berg Lipidtech AS (BLT) (Norway)
Biosearch, S.A. (Biosearch Life) (Spain)
Bluebiotech International GmbH (Germany)
Brudy Technology S.L. (Spain)
COPALIS (France)
Croda International Plc (United Kingdom)
De Wit Speciality Oils (Netherlands)
Denomega (Orkla Health) (Norway)
DSM Nutritional Products AG (Switzerland)
Epax AS (Norway)
Evonik Nutrition & Care GmbH (Germany)
Fermentalg SA (France)
Antibi?ticos de Le?n SLU (ADL Biopharma) (Spain)
Fortuna Oils AS (Norway)
GC Rieber Oils (Norway)
Henry Lamotte Oils GmbH (Germany)
Hofseth Biocare AS (Norway)
Imperial-Oel-Import Handelsgesellschaft mbH (Germany)
IQI B.V. (Netherlands)
KD Pharma Group (Switzerland)
LYSI hf. (Iceland)
Margildi EHF. (Iceland)
Minami Nutrition (Belgium)
Mowi ASA (Norway)
Noble Harvest AS (Norway)
Norwegian Fish Oil AS (Norway)
Novasep Holding SAS (France)
Olvea Fish Oils (Olvea Group) (France)
Omnipharm SAS (France)
Pharma Marine AS (Norway)
POLARIS (France)
Progress Biotech bv (The Netherlands)
Rimfrost AS (Norway)
Seafoodia (France)
SEANOVA (France)
Seven Seas Ltd (United Kingdom)
Simris Alg AB (Sweden)
Sochim International SPA (Italy)
Solutex GC, S.L. (Spain)
Stepan Lipid Nutrition (Netherlands)
Thai Union Marine Nutrients GmbH (Germany)
Triplenine Group A/S (Denmark)
True Westfjords ehf (Iceland)
Vesteraalens AS (Norway)
Veramaris V.O.F. (Netherlands)
9. ASIA-PACIFIC
9.1 Asia-Pacific Omega-3 PUFAs Market Overview by Geographic Region
9.2 Asia-Pacific Omega-3 PUFAs Market Overview by Raw Material Source
9.3 Asia-Pacific Omega-3 PUFAs Market Overview by End-Use Application
9.4 Major Market Players
AK & MN Biofarm Co Ltd (South Korea)
Arjuna Natural Pvt Ltd (India)
Avesthagen Limited (India)
Bioplus Life Sciences Pvt. Ltd. (India)
Bizen Chemical Co Ltd (Japan)
Blueline Foods (India) Pvt Ltd (India)
Chemport, Inc. (South Korea)
Clover Corporation (Nu-Mega) (Australia)
Coastal Exports Corporation (India)
ECA Healthcare Inc (China)
Ennature Biopharma (India Glycols Ltd) (India)
Fenchem Biotek Ltd (China)
Guangdong Runke Bioengineering Co Ltd (China)
Huatai Biopharm Inc. (China)
Jiangsu Auqi Marine Biotechnology Co., Ltd. (China)
Jiangsu Weisikang Food Sci-Tech Development Co., Ltd. (China)
K Pharmtech Co. Ltd. (South Korea)
Kangcare Bioindustry Co., Ltd. (China)
Kinomega Biopharm Inc. (China)
Luhua Biomarine (Shandong) Co., Ltd (China)
Maruha Nichiro Corporation (Japan)
Nippon Suisan Kaisha, Ltd. (NISSUI) (Japan)
Nisshin Pharma Inc. (Japan)
Novosana (Taicang) Co. Ltd. (China)
Phycoil Biotech Korea, Inc. (South Korea)
Qingdao Kangjing Marine Biotechnology Co., Ltd (China)
Qponics Limited (Australia)
Seadragon Marine Oils Ltd (New Zealand)
Shandong Yuwang Pharmaceutical Co., Ltd (China)
Shenzhen Qianhai Xiaozao Technology Ltd./ Lyxia Corporation (China)
Sinomega Biotech Engineering Co Ltd (China)
Skuny Bioscience Co., Ltd. (China)
Thai Union Group PCL (Thailand)
Wuxi Xunda Marine Biological Products Co., Ltd. (China)
10. SOUTH AMERICA
10.1 South American Omega-3 PUFAs Market Overview by Geographic Region
10.2 South American Omega-3 PUFAs Market Overview by Raw Material Source
10.3 South American Omega-3 PUFAs Market Overview by End-Use Application
10.4 Major Market Players
AntarcticOmega SPA (Chile)
Austral Group S.A.A. (Peru)
Colpex International S.A.C (Peru)
Corporacion Pesquera Inca S.A.C. (Peru)
Cox & Compa??a S.A. (Chile)
Fiordo Austral Group (Chile)
GIHON – Laboratorios Qu?micos Srl (Argentina)
Golden Omega SA (Chile)
Natural Oils Chile SA (Chile)
Naturmega SA (Colombia)
Pesquera Camanchaca SA (Chile)
Pesquera Diamante SA (Peru)
Pesquera Hayduk SA (Peru)
SPES S.A. (Chile)
TASA Omega SA (Tecnol?gica De Alimentos SA) (Peru)
11. REST OF WORLD
11.1 Rest of World Omega-3 PUFAs Market Overview by Raw Material Source
11.2 Rest of World Omega-3 PUFAs Market Overview by End-Use Application
PART C: OMEGA-3 PATENT LANDSCAPE
PART D: GUIDE TO THE INDUSTRY
1. MANUFACTURERS OF OMEGA-3 INGREDIENTS
2. RAW MATERIAL PRODUCERS AND EQUIPMENT SUPPLIERS
3. MAJOR INGREDIENT DISTRIBUTORS
4. OMEGA-3 END-USERS
PART E: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
CHARTS & GRAPHS
PART A: GLOBAL MARKET PERSPECTIVE
Chart 1: Global Omega-3 PUFAs Market Analysis by Geographic Region (2019, 2020 & 2026)
Chart 2: Global Omega-3 PUFAs Market Analysis by Raw Material Source (2019, 2020 & 2026)
Chart 3: Global Omega-3 PUFAs Market Analysis by End-use Application (2019, 2020 & 2026)
Chart 4: 2020 Snapshot for Global Omega-3 PUFAs Market Share by Ingredient Type
Chart 5: Global 18/12 Fish Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 6: Global Cod Liver Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 7: Global Tuna Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 8: Global Salmon Oil Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 9: Global Low Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 10: Global Medium Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 11: Global High Concentrate Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 12: Global Krill Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 13: Global Algal Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 14: Global Other Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) – Volume in Metric Tons and Value in USD Million
Chart 15: 2020 Snapshot for Global Omega3 PUFAs Market Share by End-Use Application
Chart 16: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Dietary Supplements – Volume in Metric Tons and Value in USD Million
Chart 17: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Animal Nutrition – Volume in Metric Tons and Value in USD Million
Chart 18: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Food & Beverages – Volume in Metric Tons and Value in USD Million
Chart 19: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Infant Nutrition – Volume in Metric Tons and Value in USD Million
Chart 20: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Pharmaceuticals – Volume in Metric Tons and Value in USD Million
Chart 21: Global Omega-3 PUFAs Market Analysis (2019, 2020 & 2026) in Clinical Nutrition – Volume in Metric Tons and Value in USD Million
Chart 22: Global Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 23: Global Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 24: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 25: Global Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 26: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 27: Global Omega-3 PUFAs Market Analysis (2017-2026) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 28: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 29: Global Omega-3 PUFAs Market Analysis (2017-2026) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 30: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Dietary Supplements by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 31: Global Omega-3 PUFAs Market Analysis (2017-2026) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 32: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 33: Global Omega-3 PUFAs Market Analysis (2017-2026) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 34: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Animal Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 35: Global Omega-3 PUFAs Market Analysis (2017-2026) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 36: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 37: Global Omega-3 PUFAs Market Analysis (2017-2026) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 38: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Food & Beverages by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 39: Global Omega-3 PUFAs Market Analysis (2017-2026) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 40: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 41: Global Omega-3 PUFAs Market Analysis (2017-2026) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 42: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Infant Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 43: Global Omega-3 PUFAs Market Analysis (2017-2026) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific in Metric Tons
Chart 44: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific
Chart 45: Global Omega-3 PUFAs Market Analysis (2017-2026) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific in USD Million
Chart 46: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Pharmaceuticals by Geographic Region – North America, Europe and Asia-Pacific
Chart 47: Global Omega-3 PUFAs Market Analysis (2017-2026) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 48: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 49: Global Omega-3 PUFAs Market Analysis (2017-2026) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 50: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) in Clinical Nutrition by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 51: Global Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 52: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 53: Global Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 54: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 55: Global Marine Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 56: Glance at 2017, 2020 and 2026 Global Marine Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 57: Global Marine Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 58: Glance at 2017, 2020 and 2026 Global Marine Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 59: Global Algal Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 60: Glance at 2017, 2020 and 2026 Global Algal Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 61: Global Algal Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 62: Glance at 2017, 2020 and 2026 Global Algal Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 63: Global Omega-3 PUFAs Market Analysis (2017-2026) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in Metric Tons
Chart 64: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others
Chart 65: Global Omega-3 PUFAs Market Analysis (2017-2026) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others in USD Million
Chart 66: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Ingredient Type – 18/12 Fish Oils, Tuna Oils, Cod Liver Oils, Sardine Oils, Low Concentrates (40-60%), Medium Concentrates (70-85%), High Concentrates (>85%), Krill Omega-3, Algal Omega-3 and Others
PART B: REGIONAL MARKET PERSPECTIVE
Chart 67: Global Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in Metric Tons
Chart 68: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Volume Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
Chart 69: Global Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
Chart 70: Glance at 2017, 2020 and 2026 Global Omega-3 PUFAs Value Market Share (%) by Geographic Region – North America, Europe, Asia-Pacific, South America and Rest of World
REGIONAL MARKET OVERVIEW
NORTH AMERICA
Chart 71: North American Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 72: North American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – United States, Canada and Mexico in Metric Tons
Chart 73: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 74: North American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – United States, Canada and Mexico in USD Million
Chart 75: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by Geographic Region – United States, Canada and Mexico
Chart 76: North American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 77: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 78: North American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 79: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 80: North American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 81: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 82: North American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 83: Glance at 2017, 2020 and 2026 North American Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
EUROPE
Chart 84: European Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 85: European Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in Metric Tons
Chart 86: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
Chart 87: European Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe in USD Million
Chart 88: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by Geographic Region – Denmark, France, Germany, Italy, Norway, Spain, United Kingdom and Rest of Europe
Chart 89: European Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 90: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 91: European Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 92: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 93: European Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 94: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 95: European Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 96: Glance at 2017, 2020 and 2026 European Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
ASIA-PACIFIC
Chart 97: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 98: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in Metric Tons
Chart 99: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
Chart 100: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific in USD Million
Chart 101: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Geographic Region – Australia, China, India, Japan, South Korea and Rest of Asia-Pacific
Chart 102: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 103: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 104: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 105: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 106: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in Metric Tons
Chart 107: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
Chart 108: Asia-Pacific Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition in USD Million
Chart 109: Glance at 2017, 2020 and 2026 Asia-Pacific Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition, Pharmaceuticals and Clinical Nutrition
SOUTH AMERICA
Chart 110: South American Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 111: South American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Argentina, Brazil and Rest of South America in Metric Tons
Chart 112: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by Geographic Region – Argentina, Brazil and Rest of South America
Chart 113: South American Omega-3 PUFAs Market Analysis (2017-2026) by Geographic Region – Argentina, Brazil and Rest of South America in USD Million
Chart 114: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by Geographic Region – Argentina, Brazil and Rest of South America
Chart 115: South American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 116: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 117: South American Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 118: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 119: South American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
Chart 120: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
Chart 121: South American Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
Chart 122: Glance at 2017, 2020 and 2026 South American Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
REST OF WORLD
Chart 123: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) – Volume in Metric Tons and Value in USD Million
Chart 124: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in Metric Tons
Chart 125: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Volume Market Share (%) by Raw Material Source – Marine and Algal
Chart 126: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by Raw Material Source – Marine and Algal in USD Million
Chart 127: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Value Market Share (%) by Raw Material Source – Marine and Algal
Chart 128: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in Metric Tons
Chart 129: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Volume Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
Chart 130: Rest of World Omega-3 PUFAs Market Analysis (2017-2026) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition in USD Million
Chart 131: Glance at 2017, 2020 and 2026 Rest of World Omega-3 PUFAs Value Market Share (%) by End-use Application – Dietary Supplements, Animal Nutrition, Food & Beverages, Infant Nutrition and Clinical Nutrition
TABLES:
Table 1: Types of Polyunsaturated Omega-3 Fatty Acids
Table 2: Dietary Sources of Omega-3 Fatty Acids
Table 3: Alpha-Linolenic Acid Content of Selected Foods and Oils
Table 4: Leading Plant Sources of Alpha-Linolenic Acid (ALA)
Table 5: EPA + DHA Content in Selected Fish and Seafood per 85 Gram Serving
Table 6: Omega-3 Fatty Acids EPA and DHA in Microalgae
Table 7: Forms of Omega-3 Fatty Acid Ingredients
Table 8: Microalgae Strains Characterized by EPA Production
Table 9: Microalgae Strains Characterized by DHA Production
Table 10: Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake Globally
Table 11: Omega-3 Drugs Approved to date
Table 12: Omega-3 Drugs Pipeline
Table 13: Generic Omega-3 Drugs Approved
Table 14: Quality Specifications and Regulations Related to Omega-3 Oils (After Including Data from GOED)
Table 1: Types of Polyunsaturated Omega-3 Fatty Acids
Table 2: Dietary Sources of Omega-3 Fatty Acids
Table 3: Alpha-Linolenic Acid Content of Selected Foods and Oils
Table 4: Leading Plant Sources of Alpha-Linolenic Acid (ALA)
Table 5: EPA + DHA Content in Selected Fish and Seafood per 85 Gram Serving
Table 6: Omega-3 Fatty Acids EPA and DHA in Microalgae
Table 7: Forms of Omega-3 Fatty Acid Ingredients
Table 8: Microalgae Strains Characterized by EPA Production
Table 9: Microalgae Strains Characterized by DHA Production
Table 10: Recommendations for Omega-3 Fatty Acids (EPA and DHA) Intake Globally
Table 11: Omega-3 Drugs Approved to date
Table 12: Omega-3 Drugs Pipeline
Table 13: Generic Omega-3 Drugs Approved
Table 14: Quality Specifications and Regulations Related to Omega-3 Oils (After Including Data from GOED)
The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions.
Omega-3 Polyunsatuarated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits.
There are many contributing factors that may influence the omega-3s market in the future. Though the predominance of fish oil in the global market for omega-3 has been driving the market and would continue to do so, the scenario of the future is likely to depict a contrasting picture. For one, the market has been witnessing a marked shift towards products with higher concentrations, a trend that has been more conspicuous in the developing world. This has been the consequence of consumers upgrading from lower concentrate products to higher concentrate products in a bid to get more EPA/DHA per capsule or softgel.
Products with higher concentrations offer the benefit of obtaining the similar health promoting levels of EPA and DHA, though in smaller or fewer capsules or softgels.
Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA’s or other relevant authorities’ approvals.
In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as “vegetarian,” “kosher” or even “organic.”
Expansion of market access and production capabilities of numerous players in the omega-3 space has been motivated through greater consumer awareness and demand for Omega-3 in triglyceride form. Research has established improved absorption and bioavailability of triglyceride omega-3 when compared to the ethyl ester form. Hence, manufacturers are presented with an unmatched opportunity to address the growing trend evolving from choosing omega-3 triglycerides over ethyl esters, specifically in ultrapure and highly concentrated forms.
On the other side of the coin, specifically in the United States, a negative July 2013 study on omega-3 which connected to prostate cancer risk has hampered the omega-3 market growth. United States omega-3 ingredient sales in second half of the year 2013 in dietary supplement sector has been significantly reduced compared to other application sectors. The impact is believed to be only in the US omega-3 market and there is little bit or no impact observed in Europe and Asia-Pacific regions. Omega-3 industry has been defending and will defend these negative studies in the future and omega-3 sales are expected to be growing as usual in the coming years.
